Community Pharmacy is Changing and so is Mawdsleys

Press Release

 

13 February 2018

 

Community Pharmacy is changing and so is Mawdsleys.

 

Mawdsleys, working in conjunction with its associate company the DE Group, has completed a joint strategic review of their wholesale activities. The review has concluded that customer interests and the future prospects of both organisations would benefit if they concentrate respectively on the sectors where they have specific market expertise.

 

The DE Group has developed an efficient twice-daily delivery service from eight locations serving independent community pharmacies throughout the UK. We believe that the DE Group has the most appropriate resources and infrastructure to focus on supporting independent community pharmacy in the longer term.

 

Similarly, Mawdsleys has developed an impressive Hospital wholesale business, widely acknowledged by Hospitals as the market leader for accuracy of deliveries and customer service support.  Prioritising resource and investment into secondary care will allow Mawdsleys greater flexibility to respond proactively to future market trends in the hospital sector.

 

This strategy will begin from 1st April 2018 with the process of assimilating the Mawdsleys full line retail wholesale business into the DE Group infrastructure, allowing Mawdsleys to concentrate on fulfilling its orders and delivering enhanced bespoke solutions to Hospitals.

 

Changing times call for innovative solutions and Mawdsleys and the DE Group believe this strategic collaboration will be a positive move to secure the future interests of both companies, provide opportunities for our staff, and an improved service platform for both the Independent community pharmacy and hospital sectors.

 

The DE Group are part of the Converse Pharma Group.

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-announces-new-solus-deal-with-ma-pharmachem/ thumbnail image Mawdsleys announces new solus deal with M&A Pharmachem

Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.   From 1st July 2014, Mawdsleys  will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly.   As from this date, all orders for M&A products…

Read more
https://www.mawdsleys.co.uk/news/our-portfolio-is-expanding/ thumbnail image Our portfolio is expanding

  As from 1st June we are distributing products to hospitals on behalf of Hikma Pharmaceuticals, adding to our growing portfolio of products and manufacturers.   If you are a manufacturer or hospital and want to know more about how Mawdsleys can support and work with you, contact us today…

Read more